Skip to main content
Top
Literature
1.
go back to reference Bartalena L, Kahaly GJ, Baldeschi L, Dayan CM, Eckstein A, Marcocci C, Marino M, Vaidya B, Wiersinga WM (2021) The 2021 European group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of graves’ orbitopathy. Eur J Endocrinol 185:G43–G67CrossRefPubMed Bartalena L, Kahaly GJ, Baldeschi L, Dayan CM, Eckstein A, Marcocci C, Marino M, Vaidya B, Wiersinga WM (2021) The 2021 European group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of graves’ orbitopathy. Eur J Endocrinol 185:G43–G67CrossRefPubMed
2.
go back to reference Sisti E, Coco B, Menconi F, Leo M, Rocchi R, Latrofa F, Profilo MA, Mazzi B, Vitti P, Marcocci C, Brunetto M, Marinò M (2015) Age and dose are major risk factors for liver damage associated with intravenous glucocorticoid pulse therapy for Graves’ orbitopathy. Thyroid 25:846–850CrossRefPubMed Sisti E, Coco B, Menconi F, Leo M, Rocchi R, Latrofa F, Profilo MA, Mazzi B, Vitti P, Marcocci C, Brunetto M, Marinò M (2015) Age and dose are major risk factors for liver damage associated with intravenous glucocorticoid pulse therapy for Graves’ orbitopathy. Thyroid 25:846–850CrossRefPubMed
3.
go back to reference Mieli-Vergani G, Vergani D, Czaja AJ, Manns MP, Krawitt EL, Vierling JM, Lohse AW, Montano-Loza AJ (2018) Autoimmune hepatitis. Nat Rev Dis Primers 12(4):18017CrossRef Mieli-Vergani G, Vergani D, Czaja AJ, Manns MP, Krawitt EL, Vierling JM, Lohse AW, Montano-Loza AJ (2018) Autoimmune hepatitis. Nat Rev Dis Primers 12(4):18017CrossRef
4.
go back to reference Lanzolla G, Puccinelli L, Giudetti M, Comi S, Menconi F, Maglionico MN, Posarelli C, Figus M, Marcocci C, Marinò M (2023) Anti-nuclear autoantibodies in Graves’ disease and Graves’ orbitopathy. J Endocrinol Invest 46:337–344CrossRefPubMed Lanzolla G, Puccinelli L, Giudetti M, Comi S, Menconi F, Maglionico MN, Posarelli C, Figus M, Marcocci C, Marinò M (2023) Anti-nuclear autoantibodies in Graves’ disease and Graves’ orbitopathy. J Endocrinol Invest 46:337–344CrossRefPubMed
Metadata
Title
Autoimmune hepatitis after high-dose intravenous glucocorticoids for Graves’ orbitopathy
Authors
G. Cosentino
S. Comi
B. Coco
M. Marinò
Publication date
01-04-2023
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 4/2023
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-023-02029-z

Other articles of this Issue 4/2023

Journal of Endocrinological Investigation 4/2023 Go to the issue

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more